rs4293

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000789.4(ACE):​c.417+207G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.522 in 660,340 control chromosomes in the GnomAD database, including 93,913 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.45 ( 17672 hom., cov: 33)
Exomes 𝑓: 0.54 ( 76241 hom. )

Consequence

ACE
NM_000789.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.675

Publications

25 publications found
Variant links:
Genes affected
ACE (HGNC:2707): (angiotensin I converting enzyme) This gene encodes an enzyme involved in blood pressure regulation and electrolyte balance. It catalyzes the conversion of angiotensin I into a physiologically active peptide angiotensin II. Angiotensin II is a potent vasopressor and aldosterone-stimulating peptide that controls blood pressure and fluid-electrolyte balance. This angiotensin converting enzyme (ACE) also inactivates the vasodilator protein, bradykinin. Accordingly, the encoded enzyme increases blood pressure and is a drug target of ACE inhibitors, which are often prescribed to reduce blood pressure. This enzyme additionally plays a role in fertility through its ability to cleave and release GPI-anchored membrane proteins in spermatozoa. Many studies have associated the presence or absence of a 287 bp Alu repeat element in this gene with the levels of circulating enzyme. This polymorphism, as well as mutations in this gene, have been implicated in a wide variety of diseases including cardiovascular pathophysiologies, psoriasis, renal disease, stroke, and Alzheimer's disease. Regulation of the homologous ACE2 gene may be involved in progression of disease caused by several human coronaviruses, including SARS-CoV and SARS-CoV-2. Alternative splicing results in multiple transcript variants encoding both somatic (sACE) and male-specific testicular (tACE) isoforms. [provided by RefSeq, Sep 2020]
ACE Gene-Disease associations (from GenCC):
  • renal tubular dysgenesis of genetic origin
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • intracerebral hemorrhage
    Inheritance: Unknown Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 17-63478305-G-A is Benign according to our data. Variant chr17-63478305-G-A is described in ClinVar as Benign. ClinVar VariationId is 1262835.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.617 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACENM_000789.4 linkc.417+207G>A intron_variant Intron 2 of 24 ENST00000290866.10 NP_000780.1 P12821-1B4DKH4
ACENM_001382700.1 linkc.182+207G>A intron_variant Intron 2 of 21 NP_001369629.1
ACENM_001382701.1 linkc.-198+207G>A intron_variant Intron 2 of 22 NP_001369630.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACEENST00000290866.10 linkc.417+207G>A intron_variant Intron 2 of 24 1 NM_000789.4 ENSP00000290866.4 P12821-1

Frequencies

GnomAD3 genomes
AF:
0.453
AC:
68924
AN:
152030
Hom.:
17663
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.195
Gnomad AMI
AF:
0.408
Gnomad AMR
AF:
0.584
Gnomad ASJ
AF:
0.464
Gnomad EAS
AF:
0.635
Gnomad SAS
AF:
0.577
Gnomad FIN
AF:
0.522
Gnomad MID
AF:
0.392
Gnomad NFE
AF:
0.548
Gnomad OTH
AF:
0.461
GnomAD4 exome
AF:
0.542
AC:
275439
AN:
508192
Hom.:
76241
Cov.:
6
AF XY:
0.543
AC XY:
143369
AN XY:
263880
show subpopulations
African (AFR)
AF:
0.181
AC:
2449
AN:
13522
American (AMR)
AF:
0.628
AC:
11622
AN:
18506
Ashkenazi Jewish (ASJ)
AF:
0.462
AC:
6432
AN:
13916
East Asian (EAS)
AF:
0.627
AC:
19381
AN:
30888
South Asian (SAS)
AF:
0.576
AC:
26741
AN:
46434
European-Finnish (FIN)
AF:
0.528
AC:
15187
AN:
28744
Middle Eastern (MID)
AF:
0.459
AC:
942
AN:
2052
European-Non Finnish (NFE)
AF:
0.546
AC:
178280
AN:
326326
Other (OTH)
AF:
0.518
AC:
14405
AN:
27804
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
6135
12271
18406
24542
30677
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1968
3936
5904
7872
9840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.453
AC:
68946
AN:
152148
Hom.:
17672
Cov.:
33
AF XY:
0.457
AC XY:
33989
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.194
AC:
8067
AN:
41516
American (AMR)
AF:
0.585
AC:
8949
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.464
AC:
1610
AN:
3470
East Asian (EAS)
AF:
0.635
AC:
3279
AN:
5164
South Asian (SAS)
AF:
0.578
AC:
2790
AN:
4824
European-Finnish (FIN)
AF:
0.522
AC:
5526
AN:
10590
Middle Eastern (MID)
AF:
0.378
AC:
111
AN:
294
European-Non Finnish (NFE)
AF:
0.548
AC:
37278
AN:
67974
Other (OTH)
AF:
0.457
AC:
965
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1768
3535
5303
7070
8838
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
634
1268
1902
2536
3170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.401
Hom.:
3817
Bravo
AF:
0.441
Asia WGS
AF:
0.583
AC:
2026
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
1.0
DANN
Benign
0.47
PhyloP100
-0.68
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4293; hg19: chr17-61555666; API